- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape | 246 | ACCESS Newswire | DALLAS, TX / ACCESS Newswire / April 22, 2025 / Mangoceuticals Inc. (NASDAQ:MGRX) is on a mission to rewrite the playbook for men's performance, health, and vitality. Its pursuit comes at a time when... ► Artikel lesen | |
| 17.04. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.04. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.04. | MANGOCEUTICALS, INC. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 28.03. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.03. | Mangoceuticals, Inc.: Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol in the USA and Canada | 108 | GlobeNewswire (Europe) | Diabetinol® is a clinically supported and patented plant-based nutraceutical product targeting the pre-diabetic and weight loss marketplace DALLAS, TX, March 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals... ► Artikel lesen | |
| 22.03. | Mangoceuticals verzeichnet deutliche Umsatzrückgänge im letzten Quartal | 1 | IT BOLTWISE | ||
| 20.03. | MANGOCEUTICALS, INC. - 10-K, Annual Report | 1 | SEC Filings | ||
| MANGOCEUTICALS Aktie jetzt für 0€ handeln | |||||
| 19.03. | MANGOCEUTICALS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 20.02. | Mangoceuticals Launches PeachesRx, A Women's Telehealth Brand For Wellness And GLP-1 Treatments | - | RTTNews | ||
| 19.02. | MANGOCEUTICALS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 12.02. | Mangoceuticals bekämpft Vogelgrippe mit wasserbasierter Lösung | 1 | Investing.com Deutsch | ||
| 12.02. | Mangoceuticals, Inc.: Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution | 1 | GlobeNewswire (USA) | ||
| 07.02. | MANGOCEUTICALS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 06.02. | Mangoceuticals advances in H1N1 and H5N1 studies | 1 | Investing.com | ||
| 31.01. | MANGOCEUTICALS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 15.01. | MANGOCEUTICALS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 08.01. | MANGOCEUTICALS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 26.12.24 | MANGOCEUTICALS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 19.12.24 | Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent | 2 | GlobeNewswire (USA) |
Seite:
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SPINEWAY | 0,111 | 0,00 % | Spineway: First-quarter 2025 revenue of €2.8 million | Press release Ecully, April 16, 2025 - 7.00 p.m. SPINEWAY First-quarter 2025 revenue of €2.8 million In thousands of euros20252024Change as a %Q1 revenue2,8283,070-8% Unaudited consolidated... ► Artikel lesen | |
| LOGICMARK | 0,009 | 0,00 % | LogicMark, Inc. Announces Reverse Stock Splits | LOUISVILLE, Ky., Nov. 15, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK) (the "Company"), a provider of personal emergency response systems (PERS), health communications devices, and technology... ► Artikel lesen | |
| NUWELLIS, INC | 0,941 | 0,00 % | Nuwellis, Inc.: Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision | ||
| NANOVIBRONIX | 5,117 | -0,60 % | NanoVibronix, Inc. - S-1/A, General form for registration of securities | ||
| PROCEPT BIOROBOTICS | 52,56 | 0,00 % | PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops | ||
| BRIGHTSPRING HEALTH SERVICES | 16,550 | 0,00 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., March 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,040 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance | Reports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectationsAchieves first full year of positive adjusted EBITDA as a public company, driven by operating... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,320 | +0,96 % | EQS-DD: Siemens Healthineers AG: Darleen Caron, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
22.04.2025 / 17:45... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,490 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2024 Results | SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| FRESENIUS | 39,870 | +0,05 % | ANALYSE-FLASH: Barclays senkt Ziel für Fresenius SE - 'Overweight' | LONDON (dpa-AFX Broker) - Die britische Investmentbank Barclays hat das Kursziel für Fresenius von 44,00 auf 43,50 Euro gesenkt, aber die Einstufung auf "Overweight" belassen. Die Bad Homburger dürften... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,930 | +1,13 % | Siemens Energy haussiert, Fresenius Medical Care prallt ab: DAX-Ausblick | Der DAX hat in der vergangenen Woche weiter Boden gutgemacht. Unter dem Strich legte das größte deutsche Börsenbarometer mehr als 800 Punkte zu und schloss +4,08% höher mit 21.205 Punkten. Auf dem Kaufzettel... ► Artikel lesen | |
| GERRESHEIMER | 54,15 | +1,03 % | Jetzt oder nie! Gerresheimer-Aktie mit Turnaround und Kursziel 122,50 Euro? | ||
| UNITEDHEALTH | 376,55 | +0,99 % | UnitedHealth Group: Einsteigen oder abwarten? | ||
| NUTEX HEALTH | 140,51 | 0,00 % | Nutex Health Inc. (NUTX): Among Most Expensive Stocks Insiders Are Buying After Trump's Tariff Rollout | ||
| GENEDX | 109,22 | 0,00 % | GeneDx To Buy Fabric Genomics |
MANGOCEUTICALS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 2,100 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MANGOCEUTICALS INC finden Sie auf Wallstreet Online.
